Lee Sung bought CYTK
June 29, 2026 · Form 4 insider transaction
Lee Sung bought 822 shares of Cytokinetics, Incorporated at $44.36 per share, a transaction worth $36.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
822
Price
$44.36
Total value
$36.5K
InsiderLee Sung
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 29, 2026
Filing dateJune 29, 2026
Shares owned after64,231
OwnershipDirect
10b5-1 planNo
AmendedNo